1. Home
  2. CODA vs CNTN Comparison

CODA vs CNTN Comparison

Compare CODA & CNTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coda Octopus Group Inc.

CODA

Coda Octopus Group Inc.

HOLD

Current Price

$11.99

Market Cap

155.4M

Sector

Industrials

ML Signal

HOLD

CNTN

Canton Strategic Holdings Inc. Common Stock

N/A

Current Price

$3.44

Market Cap

184.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CODA
CNTN
Founded
1994
2017
Country
United States
United States
Employees
N/A
3
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
155.4M
184.2M
IPO Year
2007
2022

Fundamental Metrics

Financial Performance
Metric
CODA
CNTN
Price
$11.99
$3.44
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
370.3K
485.4K
Earning Date
03-17-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
15.62
N/A
EPS
0.08
N/A
Revenue
$20,316,161.00
N/A
Revenue This Year
$18.28
N/A
Revenue Next Year
$12.62
N/A
P/E Ratio
$149.88
N/A
Revenue Growth
4.98
N/A
52 Week Low
$5.76
$3.15
52 Week High
$18.00
$5.27

Technical Indicators

Market Signals
Indicator
CODA
CNTN
Relative Strength Index (RSI) 41.76 31.50
Support Level $7.47 $3.15
Resistance Level $12.22 $4.78
Average True Range (ATR) 1.13 0.28
MACD -0.42 -0.09
Stochastic Oscillator 3.45 19.63

Price Performance

Historical Comparison
CODA
CNTN

About CODA Coda Octopus Group Inc.

Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company operates in three distinct business segments: the Marine Technology business, Acoustic Sensors and Material Business and the Defense Engineering Services Business. Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.

About CNTN Canton Strategic Holdings Inc. Common Stock

Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company also operates a validator node on the Canton Network to facilitate transaction validation and network operations. It also operates a clinical-stage biotech research and development arm. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.

Share on Social Networks: